Article info

Download PDFPDF
Original research
Anti-MOG antibody–associated disorders: differences in clinical profiles and prognosis in Japan and Germany

Authors

  • Jia Liu Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Masahiro Mori Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Hanna Zimmermann Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Alexander Brandt Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyDepartment of Neurology, University of California, Irvine, California, USA PubMed articlesGoogle scholar articles
  • Joachim Havla Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany PubMed articlesGoogle scholar articles
  • Satoru Tanaka Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan PubMed articlesGoogle scholar articles
  • Kazuo Sugimoto Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Satoru Oji Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan PubMed articlesGoogle scholar articles
  • Akiyuki Uzawa Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Susanna Asseyer Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Graham Cooper Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyEinstein Center for Neurosciences, Berlin, GermanyDepartment of Experimental Neurology and Center for Stroke Research, Berlin, Charité – Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Sven Jarius Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Judith Bellmann-Strobl Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Klemens Ruprecht Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Nadja Siebert Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Hiroki Masuda Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Tomohiko Uchida Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Ryohei Ohtani Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  • Kyoichi Nomura Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan PubMed articlesGoogle scholar articles
  • Edgar Meinl Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany PubMed articlesGoogle scholar articles
  • Tania Kuempfel Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany PubMed articlesGoogle scholar articles
  • Friedemann Paul Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, GermanyEinstein Center for Neurosciences, Berlin, GermanyDepartment of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Satoshi Kuwabara Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Satoshi Kuwabara, Neurology, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp
View Full Text

Citation

Liu J, Mori M, Zimmermann H, et al
Anti-MOG antibody–associated disorders: differences in clinical profiles and prognosis in Japan and Germany

Publication history

  • Received June 28, 2020
  • Revised August 27, 2020
  • Accepted September 9, 2020
  • First published November 20, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.